We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.56B
AUM Growth
-$353M
Cap. Flow
+$6.51M
Cap. Flow %
0.12%
Top 10 Hldgs %
25.14%
Holding
166
New
27
Increased
60
Reduced
40
Closed
11

Top Buys

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$61.8M
2
MNDY icon
monday.com
MNDY
+$34.2M
3
TOST icon
Toast
TOST
+$28.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$26.8M
5
AXSM icon
Axsome Therapeutics
AXSM
+$25.9M

Top Sells

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$132M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$74M
3
PANW icon
Palo Alto Networks
PANW
+$42.1M
4
XIFR
XPLR Infrastructure LP
XIFR
+$40M
5
APLS
Apellis Pharmaceuticals
APLS
+$36.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.13%
2 Technology 23.92%
3 Industrials 14.62%
4 Consumer Discretionary 8.5%
5 Energy 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTA icon
76
Prothena Corp
PRTA
$440M
$21.5M 0.39%
445,155
– –
PNR icon
77
Pentair
PNR
$10.6B
$21.4M 0.38%
330,250
+43
+0% +$2.89K
DVAX
78
DELISTED
Dynavax Technologies
DVAX
$21M 0.38%
1,425,000
+398,914
+39% +$5.61M
COGT icon
79
Cogent Biosciences
COGT
$7.07B
$21M 0.38%
2,150,000
-1,290,796
-38% -$15.3M
IMGN
80
DELISTED
Immunogen Inc
IMGN
$20.6M 0.37%
1,300,000
– –
AMLX icon
81
Amylyx Pharmaceuticals
AMLX
$2.31B
$20.4M 0.37%
1,116,837
– –
WDAY icon
82
Workday
WDAY
$39B
$20.1M 0.36%
93,420
-40,293
-30% -$9.34M
PCVX icon
83
Vaxcyte
PCVX
$8.08B
$20M 0.36%
+393,000
New +$19.4M
BILL icon
84
BILL Holdings
BILL
$4.52B
$19.9M 0.36%
+183,214
New +$20.8M
ROIV icon
85
Roivant Sciences
ROIV
$24.8B
$19.7M 0.35%
1,690,300
– –
RGEN icon
86
Repligen
RGEN
$7.03B
$18.9M 0.34%
119,000
– –
BBIO icon
87
BridgeBio Pharma
BBIO
$16.1B
$18.9M 0.34%
716,927
-224,249
-24% -$6.36M
BEPC icon
88
Brookfield Renewable
BEPC
$6.04B
$18.6M 0.33%
776,152
+301
+0% +$8.73K
KROS icon
89
Keros Therapeutics
KROS
$202M
$18.5M 0.33%
580,000
– –
RCKT icon
90
Rocket Pharmaceuticals
RCKT
$351M
$18.4M 0.33%
898,000
– –
ROL icon
91
Rollins
ROL
$18.5B
$18.3M 0.33%
+490,328
New +$19.8M
NOVT icon
92
Novanta
NOVT
$4.95B
$18.1M 0.32%
126,028
+11
+0% +$1.79K
CMS icon
93
CMS Energy
CMS
$22.7B
$17.6M 0.32%
331,358
+10,044
+3% +$582K
XIFR
94
XPLR Infrastructure LP
XIFR
$1.12B
$17.5M 0.31%
588,359
-788,779
-57% -$40M
CYTK icon
95
Cytokinetics
CYTK
$10.9B
$16.4M 0.29%
556,000
– –
VCYT icon
96
Veracyte
VCYT
$4.77B
$16.3M 0.29%
732,000
– –
INSM icon
97
Insmed
INSM
$22B
$16M 0.29%
635,185
-276,918
-30% -$6.33M
HLI icon
98
Houlihan Lokey
HLI
$8.97B
$16M 0.29%
+149,632
New +$15.4M
OKUR
99
OnKure Therapeutics
OKUR
$162M
$15.8M 0.28%
207,814
+32,814
+19% +$2.23M
MSCI icon
100
MSCI
MSCI
$41.9B
$15.2M 0.27%
29,623
-792
-3% -$416K
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Eventide Asset Management held 166 positions worth $5.56B, down 6% from $5.92B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q3 2023 filing shows 27 new, 60 increased, 40 reduced and 11 closed positions. Its largest new stake was monday.com: 203,617 shares worth $32.4M. The largest sale was Doximity, an estimated $132M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2023 buy was monday.com: 203,617 shares worth $32.4M.
  • Eventide Asset Management added most to Transmedics in Q3 2023, an estimated $61.8M increase.
  • Eventide Asset Management's biggest Q3 2023 reduction was Palo Alto Networks, cutting an estimated $42.1M.
  • Eventide Asset Management fully exited Doximity in Q3 2023, selling an estimated $132M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.56B portfolio in Q3 2023.
  • Eventide Asset Management opened 27 new positions and closed 11 in Q3 2023.
  • Eventide Asset Management's portfolio value fell 6% quarter-over-quarter to $5.56B.

Based on Eventide Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.